Literature DB >> 23224903

Effect of MRI on the management of ductal carcinoma in situ of the breast.

Melissa Pilewskie1, Carlie Kennedy, Claire Shappell, Irene Helenowski, Denise Scholtens, Nora Hansen, Kevin Bethke, Jacqueline Jeruss, Patricia Karstaedt, Seema A Khan.   

Abstract

INTRODUCTION: The accuracy of breast magnetic resonance imaging (MRI) for detection of ductal carcinoma in situ (DCIS) has prompted recommendations for its routine preoperative use, but its clinical benefit is debated. We reviewed our experience with MRI in DCIS patients to assess the utility of MRI for surgical planning.
METHODS: DCIS patients (2008-2010) were identified through a prospectively maintained database and grouped into MRI and no-MRI groups. The rates of additional biopsies, altered surgical management, and reoperation were compared. Additionally, DCIS size ascertained by mammography, MRI, and final pathology was compared.
RESULTS: Of 352 DCIS patients, 217 received MRI and 135 did not. The type of initial operation and number of reoperations were similar between the two groups, but successful breast conservation was more frequent in the no-MRI group (p = 0.06). The additional biopsy rate was 38 % in the MRI group versus 7 % in the no-MRI group; ≥2 additional biopsies were performed in 18 % of the MRI group and 2 % of the no-MRI group (p < 0.0001). These yielded a cancer diagnosis in 26 % of MRI and 33 % of no-MRI patients (p = 0.73). MRI was not superior to mammogram in detecting size of DCIS lesions preoperatively; 52 % of mammograms were accurate (within 1 cm) compared with 41 % of MRIs.
CONCLUSIONS: DCIS patients who undergo preoperative breast MRI are far more likely to undergo additional biopsies. Unless these can be demonstrated to lead to improved long-term outcomes, the utility of routine preoperative MRI in DCIS patients remains questionable.

Entities:  

Mesh:

Year:  2012        PMID: 23224903     DOI: 10.1245/s10434-012-2771-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

1.  Perioperative breast MRI is not associated with lower locoregional recurrence rates in DCIS patients treated with or without radiation.

Authors:  Melissa Pilewskie; Cristina Olcese; Anne Eaton; Sujata Patil; Elizabeth Morris; Monica Morrow; Kimberly J Van Zee
Journal:  Ann Surg Oncol       Date:  2014-01-03       Impact factor: 5.344

2.  The Impact of Preoperative Breast MRI on Surgical Management of Women with Newly Diagnosed Ductal Carcinoma In Situ.

Authors:  Diana L Lam; Jacob Smith; Savannah C Partridge; Adrienne Kim; Sara H Javid; Daniel S Hippe; Constance D Lehman; Janie M Lee; Habib Rahbar
Journal:  Acad Radiol       Date:  2019-07-05       Impact factor: 3.173

3.  MRI accurately identifies early murine mammary cancers and reliably differentiates between in situ and invasive cancer: correlation of MRI with histology.

Authors:  Devkumar Mustafi; Marta Zamora; Xiaobing Fan; Erica Markiewicz; Jeffrey Mueller; Suzanne D Conzen; Gregory S Karczmar
Journal:  NMR Biomed       Date:  2015-07-07       Impact factor: 4.044

4.  Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with ductal carcinoma in situ.

Authors:  Shi-Yi Wang; Jessica B Long; Brigid K Killelea; Suzanne B Evans; Kenneth B Roberts; Andrea Silber; Cary P Gross
Journal:  Breast Cancer Res Treat       Date:  2016-06-10       Impact factor: 4.872

5.  Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ Treatment.

Authors:  Constance D Lehman; Constantine Gatsonis; Justin Romanoff; Seema A Khan; Ruth Carlos; Lawrence J Solin; Sunil Badve; Worta McCaskill-Stevens; Ralph L Corsetti; Habib Rahbar; Derrick W Spell; Kenneth B Blankstein; Linda K Han; Jennifer L Sabol; John R Bumberry; Ilana Gareen; Bradley S Snyder; Lynne I Wagner; Kathy D Miller; Joseph A Sparano; Christopher Comstock
Journal:  JAMA Oncol       Date:  2019-07-01       Impact factor: 31.777

6.  The case for intervention bias in the practice of medicine.

Authors:  Andrew J Foy; Edward J Filippone
Journal:  Yale J Biol Med       Date:  2013-06-13

7.  Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC).

Authors:  Carlos Canelo-Aybar; Alvaro Taype-Rondan; Jessica Hanae Zafra-Tanaka; David Rigau; Axel Graewingholt; Annette Lebeau; Elsa Pérez Gómez; Paolo Giorgi Rossi; Miranda Langendam; Margarita Posso; Elena Parmelli; Zuleika Saz-Parkinson; Pablo Alonso-Coello
Journal:  Eur Radiol       Date:  2021-05-30       Impact factor: 5.315

8.  Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).

Authors:  Shinn-Huey S Chou; Justin Romanoff; Constance D Lehman; Seema A Khan; Ruth Carlos; Sunil S Badve; Jennifer Xiao; Ralph L Corsetti; Sara H Javid; Derrick W Spell; Linda K Han; Jennifer L Sabol; John R Bumberry; Ilana F Gareen; Bradley S Snyder; Constantine Gatsonis; Lynne I Wagner; Antonio C Wolff; Kathy D Miller; Joseph A Sparano; Christopher E Comstock; Habib Rahbar
Journal:  Radiology       Date:  2021-08-03       Impact factor: 29.146

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.